Pillstats
Injection, Suspension · Intramuscular

Human Papillomavirus 9-Valent Vaccine, Recombinant

Brands: Gardasil 9 · Human Papillomavirus Type 11 L1 Capsid Protein Antigen + Human Papillomavirus Type 16 L1 Capsid Protein Antigen + Human Papillomavirus Type 18 L1 Capsid Protein Antigen + Human Papillomavirus Type 31 L1 Capsid Protein Antigen + Human Papillomavirus Type 33 L1 Capsid Protein Antigen + Human Papillomavirus Type 45 L1 Capsid Protein Antigen + Human Papillomavirus Type 52 L1 Capsid Protein Antigen + Human Papillomavirus Type 58 L1 Capsid Protein Antigen + Human Papillomavirus Type 6 L1 Capsid Protein Antigen

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)798262
US makers1 labelers
Packages2
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a2464927389842025 Q12025 Q22025 Q32025 Q42026 Q1
649
Rx · 2026 Q1
595
Units dispensed
4
Quarters · since 2025 Q2

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Merck Sharp & Dohme LLC.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.